À¦°óSMÉçÇø

Lee H, Nakamura K, Narayanan S, Brown RA,ÌýArnold DL, and Alzheimer's Disease Neuroimaging Initiative. Estimating and accounting for the effect of MRI scanner changes on longitudinal whole-brain volume change measurements.ÌýNeuroimage. [PMID: 30253207; Epub: 2018/09/22]

Hauser SL, Bar-Or A, Comi G, Giovannoni G, Hartung HP, Hemmer B, Lublin F, Montalban X, Rammohan KW, Selmaj K, Traboulsee A, Wolinsky JS,ÌýArnold DL, Klingelschmitt G, Masterman D, Fontoura P, Belachew S, Chin P, Mairon N, Garren H, Kappos L, and OPERA I and OPERA II Clinical Investigators. Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis.ÌýN Engl J Med; 376(3): 221-234. [PMID: 28002679 ; F1000Prime: 727132301; Epub: 2016/12/21]

Brown RA, Narayanan S, andÌýArnold DL. Imaging of repeated episodes of demyelination and remyelination in multiple sclerosis.ÌýNeuroimage Clin; 6: 20-25. [PMID: 25610760; Epub: 2015/01/23]

Nakamura K, Guizard N, Fonov VS, Narayanan S, Collins DL, andÌýArnold DL. Jacobian integration method increases the statistical power to measure gray matter atrophy in multiple sclerosis.ÌýNeuroimage Clin; 4: 10-17. [PMID: 24266007; Epub: 2013/11/23]

Gold R, Kappos L,ÌýArnold DL, Bar-Or A, Giovannoni G, Selmaj K, Tornatore C, Sweetser MT, Yang M, Sheikh SI, Dawson KT, and DEFINE Study Investigators. Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis.ÌýN Engl J Med; 367(12): 1098-1107. [PMID: 22992073; F1000Prime: 717965926; Epub: 2012/09/21]

Caramanos Z, Fonov VS, Francis SJ, Narayanan S, Pike GB, Collins DL, andÌýArnold DL. Gradient distortions in MRI: characterizing and correcting for their effects on SIENA-generated measures of brain volume change.ÌýNeuroimage; 49(2): 1601-1611. [PMID: 19682586; Epub: 2009/08/18]